Views: 301 Author: Site Editor Publish Time: 2025-06-17 Origin: Site
The "Australian Study Tour and Technical Exchange with Animal Biotech Australia," organized by Shandong Sinder Technology Co.,Ltd. , was successfully held from June 11th to 14th, 2025.
Australia boasts a highly developed livestock economy, with the sector constituting approximately 60% of the nation's total agricultural output. The poultry industry is particularly vital.Australia leads in poultry farming technology, disease prevention, and control. Learning from its successful practices is instrumental in enhancing the knowledge base, broadening development pathways, and improving the production efficiency and farming quality of China's poultry industry.
The Chinese delegation of elite agricultural and livestock professionals received a warm welcome and hospitality from Animal Biotech Australia (ABA). Senior ABA executives, including Executive Chairman Anthony, Director David, Global Technical Managers Dr. Chris and Dr. Robbin, Global Sales Manager Philip, and Sydney Facility Manager Matthew Heslop, attended the reception. In a convivial atmosphere, both parties engaged in in-depth exchanges and discussions on poultry farming technology and disease control, fostering mutual trust and building consensus.
ABA is a leading Australian company in novel vaccine research, a GMP manufacturer, and a global supplier of live vaccines for the intensively farmed food animal industry. To provide Chinese peers with a deeper understanding of global animal disease trends and advanced prevention measures, the tour was led by Mr. Cui Guangchao, Executive Vice President of Sinder Tech. The delegation visited ABA for knowledge exchange. Experts including ABA's Executive Chairman Anthony, Sydney Facility Manager Matthew Heslop, Dr. Peter C. Scott (Associate Professor of Veterinary Immunology, University of Melbourne), Professor Glenn Browning (University of Melbourne), Dr. Chris (Global Technical Services Director, ABA), and Liu Fengxin (Mycoplasma Product Manager, Sinder Tech) delivered presentations. Topics covered included:
Global usage of live Mycoplasma vaccines
History of the Australian layer industry
Prevalent poultry diseases and Mycoplasma vaccine application in Australia
Action on AMR: Eliminating antibiotic dependency in poultry
Efficacy and cost comparison: Antibiotics vs. Immunity
These insights significantly broadened the horizons of the Chinese delegates regarding poultry disease control.
Furthermore, the delegation toured ABA's production facilities and quality control center, gaining firsthand insight into its development history, R&D capabilities, and production strength. ABA's rapid, market-driven product development capabilities left a lasting impression.
As ABA's exclusive distributor in China, Sinder Tech currently markets the live Mycoplasma gallisepticum vaccine (TS-11 strain) and the live Mycoplasma synoviae vaccine (MS-H strain). Notably, the MS-H strain vaccine is the only registered live Mycoplasma synoviae vaccine in China. Representatives from leading Chinese layer enterprises, yellow-feathered breeders, and white-feathered breeders participated in this exchange. Attendees jointly advocated for reducing antibiotic use through live Mycoplasma vaccination to address food safety concerns, further solidifying the partnership between Sinder Tech and ABA. Sinder remains committed to its mission: "Dedicated to the precise prevention and control of animal diseases, fostering healthier farming and safer food."
The successful study tour not only deepened trust between Sinder Tech and ABA, paving the way for enhanced collaboration and superior products/services for customers, but also strengthened Sinder's ties and credibility with its key clients. It provided partners with an invaluable international perspective to benchmark against advanced global farming practices, thereby improving farming quality and production efficiency.
